# Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)

> **NCT01294462** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 801 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel
- **DRUG:** Acetylsalicylic acid ASA

## Key facts

- **NCT ID:** NCT01294462
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 801 (ACTUAL)
- **Last updated:** 2014-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294462, "Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01294462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*